Endotherapy Devices Market is estimated to reach USD 6.63 Billion by 2030 with a CAGR of 5.1%

The Global Endotherapy Devices Market size was valued at USD 3.84 Billion in 2019 and is predicted to reach USD 6.63 Billion by 2030 with a CAGR of 5.1% from 2020-2030.

Endotherapy is the therapeutic procedure that involves the application of endoscopy devices, which are either planted in the body via natural openings or through incisions, especially in case of arthroscopy. Endoscopy is done for diagnosis, prevention, and treatment of complications in the visceral organs. Endoscopy devices are widely used in cases of targeted diseases such as colon cancer and gastrointestinal disorders, through minimally invasive techniques to treat the patient. It is also performed post-surgeries in order to detect complications. Endotherapy is generally safe but may give rise to complications such as infection and bleeding.

Access Full Description of this report at:-

https://www.nextmsc.com/report/endotherapy-devices-market

Top Companies: Hoya Corporation, Olympus Corporation, Stryker Corporation, Boston Scientific Corporation, Fujifilm Holdings Corporation, Conmed Corporation Medtronic Plc., Karl Storz GmbH & Co. KG, Smith & Nephew, Plc, and Johnson & Johnson., B. Braun Melsungen AG

Market Dynamics and Trends:

Endotherapy devices market is primarily driven by increasing prevalence of diseases such as cancer and chronic pancreatitis that require minimally invasive medical procedures. Globally, lung cancer and breast cancer are the leading causes of death among men and women respectively. Additionally, rise in geriatric population, which is at high risk of such diseases is also estimated to drive the market growth. Moreover, other factors such as preference for minimally invasive treatments and technological advancements leading to ultrahigh-definition visualization systems are also expected to augment the market growth. However, lack of skilled physicians & endoscopists, high cost of devices and infections caused by a few endotherapy devices are factors that might hamper the endotherapy devices market growth.

Request sample copy of this report at:-

https://www.nextmsc.com/Endotherapy-Devices-Market/request-sample

Market Segmentations and Scope of the Study:

The global Endotherapy devices market share has been analyzed based on product, application, end user and geography. Based on product, the market is categorized into GI devices & accessories, ERCP devices & accessories, and others. The GI devices & accessories segment is further classified into biopsy forceps, injection needles, polypectomy snares, graspers, hemoclips, and others. The ERCP devices & accessories segment is sub segmented into guide wire, sphincterotome, catheter, extraction basket, extraction balloon, balloon dilation, plastic stent, metal stents, and others. The other Endotherapy devices & accessories segment is subdivided into mouthpiece, distal end cap, polyp trap, cleaning brush, and others. Based on application, the market is segmented into bronchoscopy, arthroscopy, laparoscopy, urology endoscopy, neuro-endoscopy, gastrointestinal endoscopy, and others. Based on end users, the Endotherapy devices market is categorized into hospitals, clinics, and others. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis:

North America is estimated to hold the highest share in endotherapy devices market during the forecast period owing to its developed healthcare & research industry, growing geriatric population, rising inclination towards minimally invasive surgeries and presence of major key players in this region.

However, emerging economies such as the countries in Asia-Pacific region are also estimated to grow significantly due to rising investments, consistent upsurge in population and government support for the development of their healthcare industry.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.